secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0001104659-23-002066
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

Teladoc pre-announces Q4 revenue $633-640M; FY22 revenue $2.403-2.410B
----------------------------------------------------------------------

- FY2022 total revenue guided $2.403B-$2.410B, including ~$1B from BetterHelp.
- Q4 2022 revenue expected $633M-$640M; adjusted EBITDA outlook unchanged from prior guidance.
- Preliminary, unaudited figures subject to completion of financial close and audit.
- Company reaffirms adjusted EBITDA outlook consistent with Q3 2022 earnings release.
- Management to present at 41st Annual J.P. Morgan Healthcare Conference on Jan 9, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000110465923002066/0001104659-23-002066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000110465923002066/tm232556d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-002066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer